|Bid||119.89 x 800|
|Ask||120.57 x 1200|
|Day's Range||119.66 - 122.36|
|52 Week Range||61.61 - 128.54|
|Beta (5Y Monthly)||0.73|
|PE Ratio (TTM)||47.85|
|Earnings Date||Apr. 14, 2021 - Apr. 19, 2021|
|Forward Dividend & Yield||1.80 (1.50%)|
|Ex-Dividend Date||Apr. 14, 2021|
|1y Target Est||134.88|
Abbott Laboratories (NYSE: ABT) is one of the most consistent growth stocks you'll find in the sector. The highly diversified seller of medical devices, diagnostics, pharmaceuticals for emerging market countries, and nutrition products puts together one solid quarter after another and hasn't had an earnings disappointment in over a decade. Abbott's fourth-quarter results got a big boost from COVID-19 testing.
Abbott (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Teleflex (TFX) witnesses significant sequential improvement in segmental performance during the fourth quarter on gradual recovery of the economy.